ISFIYA, Israel, Sept. 7, 2016 /PRNewswire/ -- Check-Cap Ltd.
(Nasdaq: CHEK, CHEKW), a clinical stage medical diagnostics
company engaged in the development of an ingestible capsule for
preparation-free, colorectal cancer screening, today announced that
Bill Densel, Chief Executive
Officer, will present at the Rodman & Renshaw 18th
Annual Global Investment Conference on Tuesday, September 13, 2016 at 5:30pm ET in New York
City.
To access a live webcast of this presentation, please visit
http://ir.check-cap.com/. A replay will be available for 90 days
following the presentation.
Colorectal cancer is the second leading cause of cancer death in
the U.S., with an estimated 134,000 diagnoses and 49,000 deaths in
2016. Despite compelling evidence that screening can detect
colorectal cancer and precancerous polyps, nearly one-third of the
recommended adult population has never been screened. The
Check-Cap system was designed to improve the patient experience by
eliminating the features of existing screening methods, such as
bowel preparation, invasive procedure, and stool handling, that
pose a barrier to test completion.
About Check-Cap
Check-Cap is a clinical-stage medical diagnostics company
developing the world's first ingestible capsule system for
preparation-free, less-invasive colorectal cancer screening.
The capsule utilizes innovative ultra-low dose X-ray and
wireless communication technologies to scan the inside of the colon
as it moves naturally, while the patient follows his or her normal
daily routine. After passage, the system generates a 3D
map of the inner surface of the colon which enables detection of
polyps and cancer. Designed to increase the willingness of
individuals to participate in recommended colorectal cancer
screening, the Check-Cap system addresses many frequently-cited
barriers, including laxative bowel preparation, invasiveness, and
sedation. The Check-Cap system is currently not cleared for
marketing in any jurisdiction.
Legal Notice Regarding Forward-Looking Statements
This press release contains "forward-looking statements."
Words such as "may," "should," "could," "would," "predicts,"
"potential," "continue," "expects," "anticipates," "future,"
"intends," "plans," "believes," "estimates," and similar
expressions, as well as statements in future tense, often signify
forward-looking statements. Forward-looking statements should
not be read as a guarantee of future performance or results and may
not be accurate indications of when such performance or results
will be achieved. Forward-looking statements are based on
information that the Company has when those statements are made or
management's good faith belief as of that time with respect to
future events, and are subject to risks and uncertainties that
could cause actual performance or results to differ materially from
those expressed in or suggested by the forward-looking
statements. For a discussion of these and other risks that
could cause such differences and that may affect the realization of
forward-looking statements, please refer to the "Special Note On
Forward-looking Statements" and "Risk Factors" in the Company's
Annual Report on Form 20-F and other filings with the Securities
and Exchange Commission (SEC). Investors and security holders are
urged to read these documents free of charge on the SEC's web site
at http://www.sec.gov. The Company assumes no obligation to
publicly update or revise its forward-looking statements as a
result of new information, future events or otherwise.
CONTACT:
Investors
David Carey
Lazar Partners Ltd.
212-867-1768
dcarey@lazarpartners.com
Vivian Cervantes
PCG Advisory
212-554-5482
vivian@pcgadvisory.com
Media
Danielle Lewis
Lazar Partners Ltd.
212-843-0211
dlewis@lazarpartners.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/check-cap-to-present-at-the-rodman--renshaw-18th-annual-global-investment-conference-on-september-13-2016-300323689.html
SOURCE Check-Cap Ltd.